CORDLIFE GROUP

flyersummer
Offline
Junior Member

10 years 9 months ago #15501 by flyersummer

Replied by flyersummer on topic CORDLIFE GROUP

Cordlife Group Ltd is undervalued compared to its Price of $1.06 per share, has about average safety, and is currently rated a Buy.

www.scribd.com/doc/157964809/Cordlife-Group-Ltd-docx

Please Log in or Create an account to join the conversation.

Rock
Offline
Junior Member

10 years 8 months ago #15605 by Rock

Replied by Rock on topic CORDLIFE GROUP

CORDLIFE PHILIPPINES LAUNCHES UMBILICAL CORD
TISSUE BANKING

- Additional option for storing of children’s stem cells allows child
and family to have access to wider range of future medical
treatments

- Capitalise on fast rising Philippines middle class, where per capita
disposable income is projected to increase 157% from 2007 to 2015

- In line with Cordlife’s growth plans to offer complementary
services to its clients

infopub.sgx.com/Apps?A=COW_CorporateAnno...ss_release_final.pdf

Please Log in or Create an account to join the conversation.

Rock
Offline
Junior Member

10 years 8 months ago #15617 by Rock

Replied by Rock on topic CORDLIFE GROUP

FIL Ltd on 6th August 2013 bought 358k Cordlife shares @ average $1.13. This raised its holding from 20.567 million shares (8.85%) to 20.925 million shares (9.0%)

Please Log in or Create an account to join the conversation.

Rock
Offline
Junior Member

10 years 8 months ago #15725 by Rock

Replied by Rock on topic CORDLIFE GROUP - POTENTIAL GEM WHY SELL

Joes had ask me: Cordlife is a fantastic performer, why not take profit?

Well this is a very interesting question. Many of us are tempted to cash out.

Many for-runners in this forum I believe have already sold out. Some may have sold out too early, other may be lucky to sell at its peak.

Observer2 had confess: – “I am a bad trader and I have stopped selling a stock and buying it back at a lower level. In theory it is so easy and attractive to do but in practice, it is mostly disastrous. I fully agree with Observer2 as I myself is not a good trader.”

I like to put forward this question:

You buy low, then sell high. Then what do you do with your profits at that point of time. Buy higher, sell lower? It’s always a zero-sum game. Too often we will lost focus and end up missing the boat because very few people would like to buy at much higher price as proven.

I believe in building up a strong portfolio of ‘CORE STOCKS’. CORDLIFE is one of my core stocks. Although it is already fairly price, it has good growth potential. Its oversea acquisition is gradually taking shape, revenue is growing and good profit margin. Dividend of about 3% may not be very attractive but is not too bad. 3% is still better than ST average of 2.6%. If there are other more attractive stocks and when fund are needed for other more attractive stocks than that may be a good reason to cash out or reduce holding for another stock as core stock. "Why sell the goose that going to lay the golden eggs" What needed is patient and keep track of bussiness growth.

I have bought excess Cordlife share on several occasion on price weakness and sold off on price resistance but the core holding percentage will still stay the same.

The key is not to sell off potential growth stock at its early stage of growth like CORDLIFE which have the potential of becoming another GEM. The true is very few of us are will to buy into stocks like Super Group, Osim, Raffles Hospital and Vicom, at this price.

God Bless

Please Log in or Create an account to join the conversation.

Rock
Offline
Junior Member

10 years 8 months ago #15822 by Rock

Replied by Rock on topic CORDLIFE GROUP - POTENTIAL GEM WHY SELL

Cordlife this morning power more than 15% to as high as $1.27 probably expecting a set of strong result soon.

Please Log in or Create an account to join the conversation.

Rock
Offline
Junior Member

10 years 8 months ago #15842 by Rock

Replied by Rock on topic CORDLIFE GROUP - POTENTIAL GEM WHY SELL

CORDLIFE FY2013
Gross Margin increased from 71% to 73%

Exclude one-off disposal gain of $2.7 millions
Excluding one-time non recurring cost of $1.0 million in FY2013
IPO expenses of $1.9 millions recorded in the income statement in FY2012.

Net profit after tax would still have increased by 33.6% year-on-year as compare to revenue growth of 14.6%

The CEO said CORDLIFE oversea cord blood and cord tissue banking bussiness in India, Phillippines, Hong Kong ^ Indonesia is now well positioned to capitalise on the tremendious opportunities in these economise diven by rising affluence of the middle-class.

infopub.sgx.com/Apps?A=COW_CorporateAnno...Results_PR_FINAL.pdf

Please Log in or Create an account to join the conversation.

Time to create page: 0.234 seconds